The proposed NGS-Based RNA-Sequencing market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics.
The NGS-based RNA seq market was valued at US$ 1,414.59 million in 2018 and it is projected to reach US$ 7,984.90 million in 2027; it is expected to grow at a CAGR of 19.3% from 2018 to 2027.
The NGS based RNA seq is done without a reference sequence for the strand-specific libraries that are being profiled for the rare and novel therapeutics. It is highly revolutionized study of the transcriptome which is highly sensitive and accurate for the measurement of the expression all over the transcriptome. The NGS based RNA seq provides researchers with visibility for previously undetected changes occurring in disease states, in response to therapeutics caused by different environmental conditions. In addition, this technique enables researchers to detect the known and unknown features in single assay. Moreover it assists in detecting the gene fusions, single nucleotide variants, transcript isoforms and other features without the restriction of prior data. The growth of the global NGS-based RNA seq market is attributed to the reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer. However, risks related to genetic data and high cost of NGS instruments are the major factor hindering the market growth.
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis - https://www.theinsightpartners.com/sample/TIPBT00002556/
Furthermore, the NGS-Based RNA-Sequencing market full research study is designed on account of the fact that each segment is individually assessed and then collated to form the whole market, the study can be tailor-made to fit your exact requirements.
The structure of the NGS-Based RNA-Sequencing market report can be categorized into following sections:
Section 1: scope of the report & research methodology
Section 2: key takeaways
Section 3: market variables & their impact on growth and analytical tools providing high level insights into the market dynamics and growth pattern
Section 4: market estimates and forecasts (with the base year as 2019, historic information of 2016 & 2018 and forecast from 2021 to 2027). Regional and country level estimates and forecasts for each category which are summed up to form the global market.
Section 5: competitive landscape. Attributes such as strategy framework, competitor categorization are included to provide elaborate details on the market structure & strategic undertakings as well as their impact.
Product & Services -Based Insights
In terms of product & services, the global NGS-based RNA seq market is segmented into sample preparation, sequencing services, sequencing platforms & consumables and data analysis, storage & management. In 2018, the sequencing platforms & consumables segment held largest share of the market. However, the data analysis, storage & management segment is estimated to register the highest CAGR during the forecast period.
Technology -Based Insights
Based on technology, the global NGS-based RNA seq market is segmented into sequencing by synthesis (SBS), nanopore sequencing, ion semiconductor sequencing and single-molecule real-time (SMRT) sequencing. The sequencing by synthesis segment held the largest market share in 2018, also the same segment is estimated to grow at the fastest rate during the forecast period.
Application-Based Insights
In terms of application, the global NGS-based RNA seq market is segmented into diagnostics, drug discovery, precision medicine and others. In 2018, the diagnostics segment held largest share of the market. The same segment is expected to register the highest CAGR during the forecast period.
The prominent/emerging players in the NGS-Based RNA-Sequencing market research include:
· Thermo Fisher Scientific Inc.
· Illumina Inc.
· Pacific Biosciences of California, Inc.
· F. Hoffman-La Roche Ltd
· Agilent Technologies
· BGI
· Oxford Nanopre Technologies
· Eurofins Scientific
· Qiagen
· Perkinelmer Inc
The NGS-Based RNA-Sequencing market company profiles are individually represented for all major participants and indices such as financial performance, strategic initiatives, product portfolio & company overview.
Have a 15-minute-long discussion with the lead analyst and author of the report in a time slot decided by you. You will be briefed about the contents of the report and queries regarding the scope of the document will be addressed as well –
https://www.theinsightpartners.com/speak-to-analyst/TIPBT00002556
Company overview:
Company overview provides the information about location of the company where it is headquartered along with the established year, employee strength as of 2017, regions where the company is operating and the key business areas.
Financial performance:
Overall company/segment revenue for the year 2019, 2018, and 2017 is provided in the sub title “financial performance” (public listed companies) along with the analysis and explanation of the increase or decrease in the same due to factors such as mergers & acquisition, profit or loss in any strategic business unit (sbus) and others.
Product benchmarking:
Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features.
Strategic initiatives:
Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section.
Immediate delivery of our off-the-shelf reports and prebooking of upcoming studies, through flexible and convenient payment methods –
https://www.theinsightpartners.com/buy/TIPBT00002556/
The NGS-Based RNA-Sequencing market research study is designed keeping in focus all the major countries. Although, all these countries & their market trends were accounted for while composing it, detailed sections are available for only the spearheads. In case if you would be interested in specific countries which are not covered in the current scope, kindly share the list & we can customize the study based on the geographical scope defined by you.
About us:
The insight partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as semiconductor and electronics, aerospace and defense, automotive and transportation, NGS-Based RNA-Sequencing, healthcare it, manufacturing and construction, medical device, technology, media and telecommunications, chemicals and materials.
Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis.
Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc.; which helps our clients to get a deeper analysis on various research topics.
Contact us:
If you have any queries about this report or would like further information, please contact us:
North america: +1 646 491 9876
Asia-pacific: +91 20 6727 8686
Email: [email protected]
